Loading...
01/10 19:55
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: while there are positive aspects such as increased EPS and shareholder returns, there are significant concerns about regulatory challenges, particularly with the NJOY ACE withdrawal and impairment charge. The Q&A reveals management's confidence in pricing strategies but acknowledges consumer pressures and market uncertainties. The overall sentiment is balanced by these opposing factors, leading to a neutral prediction for stock price movement.
Earnings Per Share (EPS) $1.23, an increase from $1.19 year-over-year.
Adjusted Operating Companies Income (OCI) - Smokeable Products Increased by 2.7%, with adjusted OCI margins at 64.4%, up 4.2 percentage points year-over-year due to robust net price realization of 10.8%.
Domestic Cigarette Volumes Declined by 13.7%, adjusted for calendar differences, estimated decline of 12% year-over-year, attributed to growth of illicit flavored disposable e-vapor products and economic pressures on consumers.
Cigarette Industry Volume Decline Estimated decline of 9% year-over-year, influenced by the growth of illicit e-vapor products and consumer economic pressures.
Oral Tobacco Products Segment Adjusted OCI Over $400 million, with adjusted OCI margins at 69.2%, slightly down from the previous year.
Total Shipment Volume - Oral Tobacco Products Decreased by 5%, with ON! growth offset by lower MST volumes.
Adjusted Equity Earnings from ABI $146 million, down 11.5% year-over-year due to a lower ownership interest.
Dividends Paid Approximately $1.7 billion in the first quarter.
Share Repurchases 5.7 million shares repurchased for $326 million.
Total Debt to EBITDA Ratio 2.1 times, in line with the target of approximately two times.
Impairment Charge $873 million noncash impairment charge due to ITC orders affecting NJOY ACE.
ON! Growth: ON! reported shipment volume grew to over 39 million cans, representing 18% growth in the first quarter.
New Campaign: Helix launched the 'It’s ON!' campaign, increasing consumer impressions by nearly five times to over 200 million.
NJOY Product Pipeline: NJOY plans to broaden its pipeline of innovative e-vapor products following the acquisition.
E-vapor Market Growth: The e-vapor category grew to over 20 million vapers, with disposable vapers increasing to approximately 14 million.
Illicit E-vapor Market: Illicit e-vapor products now represent more than 60% of the category.
Adjusted OCI Growth: The smokeable products segment grew adjusted operating company’s income by 2.7%.
Dividends and Share Repurchases: Altria paid approximately $1.7 billion in dividends and repurchased 5.7 million shares for $326 million.
Regulatory Advocacy: Altria is advocating for regulatory reforms to address the illicit e-vapor market.
NJOY Compliance Issues: NJOY discontinued the importation of NJOY ACE due to ITC orders, impacting its market presence.
Illicit E-Vapor Market: The e-vapor category is significantly impacted by the illicit flavored disposable market, which now represents over 60% of the category. This growth in illicit products poses a challenge for legitimate manufacturers like NJOY.
Regulatory Challenges: NJOY faces regulatory challenges due to the ITC’s exclusion order and cease and desist orders, which have limited its ability to compete in the e-vapor market.
Economic Pressures on Consumers: Smokers are experiencing economic pressure due to inflation exceeding wage growth, leading to a decline in domestic cigarette volumes and increased demand for discount products.
Supply Chain and Tariff Impacts: The company is monitoring the potential impacts of increased tariffs on costs and consumer purchasing behaviors, which could further affect sales.
Market Competition: The competitive landscape is challenging, with the growth of discount cigarette segments and the need for Altria to adapt its product offerings to maintain market share.
NJOY ACE Withdrawal: The withdrawal of NJOY ACE from the market due to regulatory issues is seen as a setback for the e-vapor category, limiting FDA-authorized choices for consumers.
Impairment Charge: An interim impairment assessment resulted in a noncash impairment charge of $873 million related to the NJOY acquisition, reflecting the challenges faced in the e-vapor market.
ON! Growth: ON! reported shipment volume grew to over 39 million cans, representing 18% growth, and expanded its share of the oral tobacco category to 8.8%.
E-vapor Strategy: Altria is focused on regulatory reforms to address the illicit e-vapor market and is advocating for stronger enforcement against illicit actors.
NJOY Acquisition: Altria plans to refine and strengthen its e-vapor product portfolio following the NJOY acquisition, despite challenges faced by NJOY in the current market.
Shareholder Returns: Altria continues to provide strong cash returns to shareholders through dividends and share repurchases.
2025 EPS Guidance: Altria expects full-year adjusted diluted EPS in the range of $5.30 to $5.45, representing a growth rate of 2% to 5% from a base of $5.19 in 2024.
Impact of Tariffs: Guidance includes limited impact of increased tariffs on costs and potential consumer purchasing behavior.
Volume Assumptions: Guidance assumes limited impact on combustible and e-vapor product volumes from enforcement efforts in the illicit e-vapor market.
Dividends Paid: Approximately $1.7 billion in dividends paid in Q1 2025.
Share Repurchases: Repurchased 5.7 million shares for $326 million in Q1 2025.
Remaining Share Repurchase Program: $674 million remaining under the current share repurchase program, expected to be completed by the end of the year.
The earnings call presents a mixed but overall positive picture. Strong financial metrics include an increase in oral tobacco margins and cigarette retail share. Despite a decline in shipment volume, the growth in the on! product line and increased retail share are positives. The Q&A reveals confidence in future performance and strategic initiatives like international expansion and product differentiation. Although there are concerns about deceleration in earnings growth and competitive pressures, the raised EPS guidance and share repurchase plan are positive signals. Given these factors, a positive stock price movement is likely.
The earnings call presents a mixed outlook. While there are positive aspects like growth in the on! brand and strategic initiatives, there are also concerns such as the NJOY ACE market re-entry and challenges from illicit vapes. The guidance is cautious with a modest EPS growth projection. The Q&A highlights uncertainties, particularly regarding competitive challenges and regulatory issues. Overall, the sentiment is balanced, with no strong positive or negative indicators.
The earnings call presents a mixed picture: while there are positive aspects such as increased EPS and shareholder returns, there are significant concerns about regulatory challenges, particularly with the NJOY ACE withdrawal and impairment charge. The Q&A reveals management's confidence in pricing strategies but acknowledges consumer pressures and market uncertainties. The overall sentiment is balanced by these opposing factors, leading to a neutral prediction for stock price movement.
The earnings call presents a mixed picture: strong shareholder returns through dividends and share repurchases, growth in smoke-free products, and strategic goals focused on future growth. However, the negative impact of the ITC orders, impairment charges, and declining cigarette volumes due to economic pressures and illicit market challenges offset these positives. The Q&A reveals consumer pressure from inflation and management's cautious approach to the discount segment and tariffs. Overall, the sentiment is balanced, suggesting minimal stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
